Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria von Sabag, D. A., Matanes, L., Bejar, J., Sheffer, H., Barzilai, A., Church, M. K., Toubi, E., Maurer, M., Vadasz, Z.

Volltext

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria von Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A. H., Baker, D., Ballmer‐Weber, B., Bernstein, J. A., Bindslev‐Jensen, C., Brzoza, Z., Buense Bedrikow, R., Canonica, G. W., Church, M. K., Craig, T., Danilycheva, I. V., Dressler, C., Ensina, L. F., Giménez‐Arnau, A., Godse, K., Gonçalo, M., Grattan, C., Hebert, J., Hide, M., Kaplan, A., Kapp, A., Katelaris, C. H., Kocatürk, E., Kulthanan, K., Larenas‐Linnemann, D., Leslie, T. A., Magerl, M., Mathelier‐Fusade, P., Meshkova, R. Y., Metz, M., Nast, A., Nettis, E., Oude‐Elberink, H., Rosumeck, S., Saini, S. S., Sánchez‐Borges, M., Schmid‐Grendelmeier, P., Staubach, P., Sussman, G., Toubi, E., Vena, G. A., Vestergaard, C., Wedi, B., Werner, R. N., Zhao, Z., Maurer, M.

Volltext

Cyclosporine-A in severe chronic urticaria: the option for long-term therapy von Kessel, A, Toubi, E

Volltext

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update von Zuberbier, T, Aberer, W, Asero, R, Bindslev-Jensen, C, Brzoza, Z, Canonica, G W, Church, M K, Ensina, L F, Giménez-Arnau, A, Godse, K, Gonçalo, M, Grattan, C, Hebert, J, Hide, M, Kaplan, A, Kapp, A, Abdul Latiff, A H, Mathelier-Fusade, P, Metz, M, Nast, A, Saini, S S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Simons, F E R, Staubach, P, Sussman, G, Toubi, E, Vena, G A, Wedi, B, Zhu, X J, Maurer, M

Volltext

Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis von Kudryavtsev, I., Serebriakova, M., Starshinova, A., Zinchenko, Y., Basantsova, N., Malkova, A., Soprun, L., Churilov, L. P., Toubi, E., Yablonskiy, P., Shoenfeld, Y.

Volltext

Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence von Maurer, M, Metz, M, Bindslev-Jensen, C, Bousquet, J, Canonica, G W, Church, M K, Godse, K V, Grattan, C E, Hide, M, Kocatürk, E, Magerl, M, Makris, M, Meshkova, R, Saini, S S, Sussman, G, Toubi, E, Zhao, Z, Zuberbier, T, Gimenez-Arnau, A

Volltext

The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years von Schichter-Konfino, V, Mubariki, R, Toubi, E, Vadasz, Z

Volltext

Semaphorin 3A – a marker for disease activity and a potential putative disease-modifying treatment in systemic lupus erythematosus von Vadasz, Z, Toubi, E

Volltext

Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria von Giménez-Arnau, A. M., Toubi, E., Marsland, A. M., Maurer, M.

Volltext

Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients von Toubi, E., Kessel, A., Avshovich, N., Bamberger, E., Sabo, E., Nusem, D., Panasoff, J.

Volltext

The role of increased T helper cell 2 cytokine expression in skin weals of chronic spontaneous urticaria: are they always activating cytokines? von Vadasz, Z., Toubi, E.

Volltext

Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study von Moldovan, D., Reshef, A., Fabiani, J., Kivity, S., Toubi, E., Shlesinger, M., Triggiani, M., Montinaro, V., Cillari, E., Realdi, G., Cancian, M., Visscher, S., Zanichelli, A., Relan, A., Cicardi, M.

Volltext

Neuropilins and semaphorins — from angiogenesis to autoimmunity von Vadasz, Z, Attias, D, Kessel, A, Toubi, E

Volltext

The Role of CD4+CD25+ T Regulatory Cells in Autoimmune Diseases von Toubi, E.

Volltext

Low levels of the immunoregulator Semaphorin 4D (CD100) in sera of HIV patients von Vadasz, Z., Elbirt, D., Radian, S., Bezalel-Rosenberg, S., Mahlab-Guri, K., Toubi, E., Asher, I., Sthoeger, Z.

Volltext

Increased killer B cells: are they associated with increased viral load and autoimmunity in patients with chronic hepatitis C virus infection? von Zuckerman, E, Eiza, N, Carlebach, M, Rainess, T, Goldberg, Y, Toubi, E, Vadas, Z

Volltext

Controversies and challenges in the management of chronic urticaria von Staubach, P., Zuberbier, T., Vestergaard, C., Siebenhaar, F., Toubi, E., Sussman, G.

Volltext

Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity von Toubi, E., Gordon, S., Kessel, A., Rosner, I., Rozenbaum, M., Shoenfeld, Y., Zuckerman, E.

Volltext

Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy von SNIR, A, KESSEL, A, HAJ, T, ROSNER, I, SLOBODIN, G, TOUBI, E

Volltext

Diagnostic dilemmas in chronic urticaria von Toubi, E., Grattan, C., Zuberbier, T.

Volltext